CMIRX Mutual Fund

NAV$10.12

Fund Essentials - as of Mar 31, 2026

Net Assets
$3M
Expense Ratio
1.25%
Dividend Yield (Current)
0.90%
Holdings
30
Inception Date
Dec 17, 2021
Fund Family
Conestoga Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+14.19%
1 Year+25.01%
3 Year+13.15%

Asset Allocation

Stocks: 98.39%
Cash: 1.61%

Top Holdings

View All →
TickerNameWeight
MMMBMamamancini's Holdings Inc5.68%
TWSTTwist Bioscience Corp.(twst)5.47%
PLMRPalomar Holdings Inc4.99%
VCELVericel Corp4.57%
TRNSTranscat Inc4.46%
Top 10 Concentration: 45.38%Report Date: Mar 31, 2026
Download all 30 holdings for CMIRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.90%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

CMIRX Mutual Fund Overview

CMIRX Mutual Fund (Conestoga Discovery Fund Class Institutional) is managed by Conestoga Funds with $3.2M in net assets. CMIRX expense ratio is 1.25%, holding 30 positions across sectors including Industrials, Health Care, Unknown. Inception date: 2021-12-17.

CMIRX performance shows a YTD return of 14.19%. The 1-year return is 25.01%. CMIRX dividend yield stands at 0.90%, paid annually.

CMIRX top holdings include Mamamancini's Holdings Inc (5.7%), Twist Bioscience Corp.(twst) (5.5%), Palomar Holdings Inc (5.0%), Vericel Corp (4.6%), Transcat Inc (4.5%). View all CMIRX holdings, sector breakdown, or dividend history.

CMIRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CMIRX alternatives are available via the screener, along with tax-loss harvesting opportunities.